Schedule 13G ownership disclosure
Anchiano Therapeutics Ltd.
Security class unavailable · CUSIP: 03280X102
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 8,868,546
- Percent of class
- 21.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000905718-20-000006
- Form type
- SC 13G
- Filer
- Chemomab Therapeutics Ltd.
- CIK
- CIK 1534248
- Filed
- Jan 02, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership